116 related articles for article (PubMed ID: 35848652)
1. The biphasic phenomenon of cytokine storm in COVID pneumonia.
Shah NM; Khambholja JR; Suthar NN; Purohit HM
Ann Afr Med; 2022; 21(2):168-172. PubMed ID: 35848652
[TBL] [Abstract][Full Text] [Related]
2. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
[TBL] [Abstract][Full Text] [Related]
3. An enlightening role for cytokine storm in coronavirus infection.
Zhao Z; Wei Y; Tao C
Clin Immunol; 2021 Jan; 222():108615. PubMed ID: 33203513
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanisms responsible for acute coronary events in COVID-19.
Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
Chong ZZ; Souayah N
Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
[TBL] [Abstract][Full Text] [Related]
6. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.
Jiang Y; Rubin L; Peng T; Liu L; Xing X; Lazarovici P; Zheng W
Int J Biol Sci; 2022; 18(2):459-472. PubMed ID: 35002503
[TBL] [Abstract][Full Text] [Related]
7. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
Soy M; Keser G; Atagündüz P; Tabak F; Atagündüz I; Kayhan S
Clin Rheumatol; 2020 Jul; 39(7):2085-2094. PubMed ID: 32474885
[TBL] [Abstract][Full Text] [Related]
8. Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.
Syam AF; Pitoyo CW; Suhendro S; Zulkarnain B; Indrasari ND; Aditianingsih D; Irawan C; Susilo A; Rumende CM; Wijaya IP; Ibrahim F; Rasmin M; Alwi I; Makmun D
Acta Med Indones; 2021 Apr; 53(2):194-201. PubMed ID: 34251348
[TBL] [Abstract][Full Text] [Related]
9. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
Front Immunol; 2021; 12():589095. PubMed ID: 33995341
[TBL] [Abstract][Full Text] [Related]
10. Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1.
Saleki K; Banazadeh M; Miri NS; Azadmehr A
Rev Neurosci; 2022 Feb; 33(2):147-160. PubMed ID: 34225390
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of the immune response in coronavirus disease 2019.
Mohamed Khosroshahi L; Rezaei N
Cell Biol Int; 2021 Apr; 45(4):702-707. PubMed ID: 33289192
[TBL] [Abstract][Full Text] [Related]
12. Favorable COVID-19 course despite significant comorbidities in a ruxolitinib-treated patient with primary myelofibrosis.
Koschmieder S; Jost E; Cornelissen C; Müller T; Schulze-Hagen M; Bickenbach J; Marx G; Kleines M; Marx N; Brümmendorf TH; Dreher M
Eur J Haematol; 2020 Nov; 105(5):655-658. PubMed ID: 32593209
[TBL] [Abstract][Full Text] [Related]
13. Hypoxemia and Cytokine Storm in COVID-19: Clinical Implications.
Machado C; González-Quevedo A
MEDICC Rev; 2021; 23(3-4):54-59. PubMed ID: 34516537
[TBL] [Abstract][Full Text] [Related]
14. [The neurology of COVID-19].
Cuevas-García C; Calderón-Vallejo A; Berrón-Ruiz L
Rev Alerg Mex; 2020; 67(4):338-349. PubMed ID: 33631902
[TBL] [Abstract][Full Text] [Related]
15. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
Torabi-Rahvar M; Rezaei N
Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
[TBL] [Abstract][Full Text] [Related]
16. Covid-19 and leptospirosis: Cytokine storm and the use of steroids.
Ittyachen AM
Trop Doct; 2021 Jan; 51(1):128-130. PubMed ID: 33236692
[TBL] [Abstract][Full Text] [Related]
17. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
Opoka-Winiarska V; Grywalska E; Roliński J
BMC Med; 2020 Jul; 18(1):214. PubMed ID: 32664932
[TBL] [Abstract][Full Text] [Related]
18. Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19.
De Virgiliis F; Di Giovanni S
Nat Rev Neurol; 2020 Nov; 16(11):645-652. PubMed ID: 32843733
[TBL] [Abstract][Full Text] [Related]
19. Cytokine storm syndrome in SARS-CoV-2: a review.
Wahid B; Rani N; Idrees M
Z Naturforsch C J Biosci; 2022 Jan; 77(1-2):65-69. PubMed ID: 34428364
[TBL] [Abstract][Full Text] [Related]
20. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.
Coperchini F; Chiovato L; Croce L; Magri F; Rotondi M
Cytokine Growth Factor Rev; 2020 Jun; 53():25-32. PubMed ID: 32446778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
